Search research articles
Contact Us
Filters
Showing results (101-110 of 137) with videos related to
Page
of 14
Sort By:
JCO Global Oncology
|
January 15, 2021
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
Kehinde Sharafadeen Okunade, Adebola A Adejimi, Ephraim O Ohazurike, et al.
Gynecologic Oncology
|
October 21, 2009
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study
Gini F Fleming, Michael W Sill, Kathleen M Darcy, et al.
Research Square
|
July 9, 2024
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): Study protocol of a randomised controlled trial
Kehinde S Okunade, Adebola A Adejimi, Temitope V Adekanye, et al.
BMC Cancer
|
June 20, 2024
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial
Kehinde S Okunade, Adebola A Adejimi, Temitope V Adekanye, et al.
JCO Global Oncology
|
September 23, 2021
Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
Kehinde S Okunade, Adaiah Soibi-Harry, Sarah John-Olabode, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2024
FIGO 2023 staging for endometrial cancer, when, if it is not now?
Xavier Matias-Guiu, Sigurd Lax, Maria Rosaria Raspollini, et al.
Plos One
|
January 26, 2023
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol
Kehinde S Okunade, Kabir B Badmos, Austin C Okoro, et al.
Research Square
|
July 29, 2024
Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria
Kehinde S Okunade, Kabir B Badmos, Austin Okoro, et al.
Journal of Global Oncology
|
July 19, 2017
Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline
Linus T Chuang, Sarah Temin, Rolando Camacho, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 26, 2014
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study
Jonathan S Berek, Robert P Edwards, Lynn P Parker, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 137) with videos related to
Sort By:
Page
of 14
JCO Global Oncology
|
January 15, 2021
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
Kehinde Sharafadeen Okunade, Adebola A Adejimi, Ephraim O Ohazurike, et al.
Gynecologic Oncology
|
October 21, 2009
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study
Gini F Fleming, Michael W Sill, Kathleen M Darcy, et al.
Research Square
|
July 9, 2024
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): Study protocol of a randomised controlled trial
Kehinde S Okunade, Adebola A Adejimi, Temitope V Adekanye, et al.
BMC Cancer
|
June 20, 2024
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial
Kehinde S Okunade, Adebola A Adejimi, Temitope V Adekanye, et al.
JCO Global Oncology
|
September 23, 2021
Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
Kehinde S Okunade, Adaiah Soibi-Harry, Sarah John-Olabode, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2024
FIGO 2023 staging for endometrial cancer, when, if it is not now?
Xavier Matias-Guiu, Sigurd Lax, Maria Rosaria Raspollini, et al.
Plos One
|
January 26, 2023
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol
Kehinde S Okunade, Kabir B Badmos, Austin C Okoro, et al.
Research Square
|
July 29, 2024
Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria
Kehinde S Okunade, Kabir B Badmos, Austin Okoro, et al.
Journal of Global Oncology
|
July 19, 2017
Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline
Linus T Chuang, Sarah Temin, Rolando Camacho, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 26, 2014
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study
Jonathan S Berek, Robert P Edwards, Lynn P Parker, et al.
Page
of 14